No Data
No Data
Sonoma Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Rule
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance With Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
Express News | Sonoma Pharmaceuticals Has Been Granted FDA 510(k) Clearance For Its Microdacyn Wound Care Solution
Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Sonoma Pharmaceuticals To Carry Out 1-for-20 Reverse Stock Split On August 30th, 2024
No Data
No Data
seb240sx : the calm before the storm